Are Checkpoint Inhibitors (that Dr. Pazdur of FDA said he is closing down Keytrudas in GBM trials) better than DcVaxL? Do you understand Immune Science? Keytruda science won the Nobel prize, but it has its own drawbacks like triggering fatal autoimmune diseases, but we don't hear those safety issues in DcVaxL. Then how could you argue DcVaxL data failed??